Clinical Trial Update: A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of the sustained-release naltrexone/bupropion combination in overweight and obese subjects has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Naltrexone SR/Bupropion SR (naltrexone/bupropion sustained-release)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21